GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirona Biochem Corp (FRA:ZSB) » Definitions » Revenue per Share

Sirona Biochem (FRA:ZSB) Revenue per Share : €0.00 (TTM As of Jan. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Sirona Biochem Revenue per Share?

Sirona Biochem's revenue per share for the three months ended in Jan. 2024 was €0.00. Sirona Biochem's revenue per share for the trailing twelve months (TTM) ended in Jan. 2024 was €0.00.

During the past 12 months, the average Revenue Per Share Growth Rate of Sirona Biochem was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.

The historical rank and industry rank for Sirona Biochem's Revenue per Share or its related term are showing as below:

During the past 13 years, Sirona Biochem's highest 3-Year average Revenue Per Share Growth Rate was 44.20% per year. The lowest was -47.70% per year. And the median was -20.60% per year.

FRA:ZSB's 3-Year Revenue Growth Rate is not ranked *
in the Biotechnology industry.
Industry Median: 3.6
* Ranked among companies with meaningful 3-Year Revenue Growth Rate only.

Sirona Biochem Revenue per Share Historical Data

The historical data trend for Sirona Biochem's Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirona Biochem Revenue per Share Chart

Sirona Biochem Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Sirona Biochem Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Sirona Biochem's Revenue per Share

For the Biotechnology subindustry, Sirona Biochem's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sirona Biochem's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sirona Biochem's PS Ratio distribution charts can be found below:

* The bar in red indicates where Sirona Biochem's PS Ratio falls into.



Sirona Biochem Revenue per Share Calculation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Sirona Biochem's Revenue Per Share for the fiscal year that ended in Oct. 2023 is calculated as

Revenue Per Share (A: Oct. 2023 )=Revenue (A: Oct. 2023 )/Shares Outstanding (Diluted Average) (A: Oct. 2023 )
=0.024/252.101
=0.00

Sirona Biochem's Revenue Per Share for the quarter that ended in Jan. 2024 is calculated as

Revenue Per Share (Q: Jan. 2024 )=Revenue (Q: Jan. 2024 )/Shares Outstanding (Diluted Average) (Q: Jan. 2024 )
=0.001/253.605
=0.00

Revenue per Share for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sirona Biochem  (FRA:ZSB) Revenue per Share Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Sirona Biochem Revenue per Share Related Terms

Thank you for viewing the detailed overview of Sirona Biochem's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Sirona Biochem (FRA:ZSB) Business Description

Traded in Other Exchanges
Address
C/o WeWork, 595 Burrard Street, Vancouver, BC, CAN, V7X 1L3
Sirona Biochem Corp is a development stage biotechnology company. The principal activities of the company are the development of cosmetic and pharmaceutical active ingredients which are licensed to partners in exchange for upfront, milestone, and royalty payments. The company acts as a cosmetic ingredient and drug discovery company with a proprietary technology platform with a specialization in the stabilization of carbohydrate molecules. It has a business presence in Canada and France.

Sirona Biochem (FRA:ZSB) Headlines

No Headlines